Vestaron raised $40m in the Novo-led round, which will support the expansion of Vestaron's range of peptide-based biopesticides.

Pharmaceutical firm Novo Holdings led a $40m series B round for US-based peptide-based biopesticide developer Vestaron yesterday. Private equity firm Open Prairie Ventures, food and agriculture-focused venture capital fund Anterra Capital and VC firms Cultivian Sandbox Ventures and Pangaea Ventures also took part in the round. Founded in 2005 as Venomix, Vestaron has built a…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.